Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity. (1st July 2022)
- Record Type:
- Journal Article
- Title:
- Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity. (1st July 2022)
- Main Title:
- Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity
- Authors:
- Liu, Yi-Chen
Yang, Ya-Dong
Liu, Wen-Qiang
Du, Ting-Ting
Wang, Ru
Ji, Ming
Yang, Bei-Bei
Li, Li
Chen, Xiao-Guang - Abstract:
- Graphical abstract: Highlights: A series of benzobis(imidazole) derivatives were found to have inhibitory activity against the IL-6 induced JAK/STAT3 signalling pathway. The most promising compound 24 could inhibit tumor cell proliferation and migration by inhibiting STAT3 signalling pathway. Compound 24 could inhibit the phosphorylation of STAT3 in tumor cells, induce tumor cells apoptosis and cycle arrest. Compound 24 could inhibit tumor growth in HepG2 xenograft model. Abstract: Polycyclic aromatic systems have been considered good biological probes, but some may also be good scaffolds for drug development. In this study, a series of benzobis(imidazole) derivatives were identified as STAT3 signal inhibitors, among which compound 24 showed significant inhibition of IL-6 induced JAK/STAT3 signalling pathway activation. Moreover, 24 inhibited cancer cell growth and migration, and induced cell apoptosis as well as cycle arrest in human hepatocellular carcinoma cells (HepG2) and oesophageal carcinoma cells (EC109). Compound 24 also displayed obvious antitumor activity in a mouse HepG2 cell xenograft tumor model without affecting the body weight. These results confirmed that 24 was a potential STAT3 signal inhibitor with certain antitumor activity.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 65(2022)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 65(2022)
- Issue Display:
- Volume 65, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 65
- Issue:
- 2022
- Issue Sort Value:
- 2022-0065-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-07-01
- Subjects:
- STAT3 -- Antitumor -- Benzobis(imidazole) -- IL-6/JAK/STAT3 signalling pathway
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2022.116757 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21511.xml